Company Filing History:
Years Active: 2016
Title: Naama Mussai: Innovator in Cannabinoid Research
Introduction
Naama Mussai is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of cannabinoid research, particularly in the development of compositions that include CB receptor agonists. Her work has implications for treating various diseases and disorders.
Latest Patents
Naama Mussai holds a patent for "Compositions comprising CB receptor agonists, uses thereof and methods for their preparation." This patent includes compositions featuring (3R, 4R, 6R)-stereoisomers of phenyl substituted pinenes, which exhibit CB receptor agonist properties. The patent outlines methods for treating diseases or disorders using these pharmaceutical compositions, as well as the processes for their preparation.
Career Highlights
Mussai is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work at this esteemed institution has allowed her to explore innovative solutions in cannabinoid research.
Collaborations
Naama has collaborated with notable researchers in her field, including Itai A Bab and Raphael Mechoulam. These collaborations have furthered her research and contributed to advancements in cannabinoid applications.
Conclusion
Naama Mussai's contributions to cannabinoid research and her innovative patent highlight her role as a leading inventor in this important field. Her work continues to pave the way for new therapeutic approaches.